AzTrials
AzTrials

Liver CirrhosesMETALICNCT03871894

Indirect Calorimeter Based Study in Patients With Liver Cirrhosis

A study testing Indirect calorimetry based nutritional intervention till patient in ICU(Intensive care unit) and Standard and fixed nutritional intervention till patient in ICU in people with Liver Cirrhoses, run by Institute of Liver and Biliary Sciences, India at 1 site in India.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Part I- Observational study In the first part , investigator would investigate and compare the energy requirements and substrate utilization in healthy subjects and in patients with liver cirrhosis of various etiologies across the disease severity state viz compensated, stable decompensated, critically ill cirrhotics. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Liver Cirrhoses
What is being tested?
Indirect calorimetry based nutritional intervention till patient in ICU(Intensive care unit) and Standard and fixed nutritional intervention till patient in ICU
Could I receive a placebo?
No, everyone receives an active treatment
How many people
83 participants
Where
1 siteIndia
Study dates
12 Mar 2019to 31 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Disease groups:
  • Patients with liver cirrhosis (diagnosis established based on routine clinical, biochemical and at least radiological, endoscopic or histological parameters.) admitted in Liver coma Intensive care unit and those admitted in ward.
  • Disease controls:
  • Patients with Acute liver failure (diagnosis established based on routine clinical, biochemical and at least radiological parameters) admitted in Liver coma Intensive care unit
  • Patients with severe acute pancreatitis (diagnosis established based on routine clinical, biochemical and at least radiological parameters) admitted in Liver coma Intensive care unit
  • Healthy Controls:
  • Healthy subjects- Relatives of patients with no known chronic diseases (Chronic obstructive pulmonary disease, Coronary artery disease, Type 2 diabetes, Hypertension, Hypothyroidism, Koch's disease) or not on any long term medications.
  • Patients with liver cirrhosis (diagnosis established based on routine clinical, biochemical and at least radiological, endoscopic or histological parameters.) admitted in Liver coma Intensive care unit who require mechanical ventilation

Who cannot join

  • Age<18 years
  • Active upper gastrointestinal bleeding
  • If there are conditions which precluded IC, such as an FiO2 >60 %, failure to cooperate, agitation, seizure activity, spasticity, or positive end-expiratory pressure (PEEP) >10 mmHg.
  • Pregnant women
  • Refused to consent/ inability to obtain informed consent.
  • Known long standing diabetic
Show all 22Show fewer
  • If there is any evidence of medical/surgical instability
  • Hepatocellular carcinoma Extrahepatic malignancies
  • With persistent gastrointestinal dysfunction and ileus
  • Patients who would be readmitted to the ICU
  • Known long standing diabetic
  • Terminally ill patients on high inotropic support
  • Acute liver failure
  • If there is any evidence of medical/surgical instability
  • If patients are taking any portion of nutrition by mouth.
  • Pregnant women
  • Refused to consent/ inability to obtain informed consent.
  • Patient on CRRT- continuous renal replacement therapy
  • Severe co morbidities such as Chronic kidney disease requiring maintenance dialysis, COPD and Cardiac pathologies (Acute myocardial infarction, heart failure, ).
  • Hepatocellular carcinoma Extrahepatic malignancies
  • Moribund patient with likely survival <24 hours
  • Patients enrolled in other drug trials.

Trial locations and contacts

1 site in 1 country.

India1 site
  • ILBS

    New Delhi, National Capital Territory of Delhi, 110070

Other trials in India

About this study

Official title: Metabolic and Clinical Effects of Enteral Nutrition Therapy: Measured Versus Estimated Energy and Substrate Requirements in Critically Ill Cirrhotics-A Randomized Controlled Trial

Part I- Observational study In the first part , investigator would investigate and compare the energy requirements and substrate utilization in healthy subjects and in patients with liver cirrhosis of various etiologies across the disease severity state viz compensated, stable decompensated, critically ill cirrhotics. The investigator would also enroll patients with chronic kidney disease, critically ill patients of acute liver failure or acute on chronic liver failure as disease controls.

Part II- Randomized Controlled Study All the eligible, critically ill cirrhotic patients on mechanical ventilator support would be randomized to a control group (receiving the nutritional therapy as per the standard enteral nutritional practice in a critical care setting) or the intervention group (receiving enteral nutrition based on proposed measured requirements by Indirect calorimetry (IC) given till the patient is in ICU(Intensive care unit). The IC would be done thrice a week in both groups.

Conditions
Liver Cirrhoses
Being tested
Indirect calorimetry based nutritional intervention till patient in ICU(Intensive care unit), Standard and fixed nutritional intervention till patient in ICU
Keywords
Indirect calorimeter, Resting energy expenditure, substrate utilization, nitrogen balance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Indirect calorimetry based nutritional intervention till patient in ICU(Intensive care unit)Other

    Nutrition therapy based on measured energy expenditure by indirect calorimetry (IC) done alternate day till patient on ventilatory support and protein intake 1.5 g/kg IBW/day

  • Standard and fixed nutritional intervention till patient in ICUOther

    Fixed standard nutritional therapy 35-40 Kcal/Kg IBW/day and 1.5 g protein /Kg IBW/Day till patient on ventilator

Study groups in NCT03871894
Study groupRoleWhat they receive
Control armActive comparatorThis is the group of critically ill cirrhotic patients on mechanical ventilator support who would receive the nutritional therapy as per the standard enteral nutritional practice in a critical care setting in cirrhotics till the period admitted in ICU(Intensive care unit) 35-40 Kcal/Kg IBW/day; 1.5g protein per kg per day.
Receives: Other: Indirect calorimetry based nutritional intervention till patient in ICU(Intensive care unit); Other: Standard and fixed nutritional intervention till patient in ICU
Intervention armExperimentalThis is the group of critically ill cirrhotic patients on mechanical ventilator support who would receive the nutritional therapy based on indirect calorimetry measurements till the period admitted in ICU(Intensive care unit); 1.5g protein per kg per day.
Receives: Other: Indirect calorimetry based nutritional intervention till patient in ICU(Intensive care unit); Other: Standard and fixed nutritional intervention till patient in ICU

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Part 1: An Observational study

    Study groups :

    1. Healthy controls
    2. Disease Groups
    • Patients with liver cirrhosis (compensated and decompensated)
    • Critically ill cirrhotics on mechanical ventilator support
    • patients with chronic kidney disease (CKD) (stable,non dialyzed, non oliguric outpatients)
    • Critically ill patients with Acute liver failure (ALF) on mechanical ventilator support
    • Critically ill patients with Acute on chronic liver failure(ACLF) on mechanical ventilator support
    • Severe acute pancreatitis on mechanical ventilator support

    Comparison of the prevalence of hyper and hypo metabolism in patients with chronic liver disease(CLD) and healthy controls and other disease groups.

    Measured: One day (Observational)

  2. Part 2: A Randomized controlled trial

    Study group:Critically ill Cirrhotic: Diagnosed cases of liver cirrhosis with 2 or more organ failures (liver + renal/circulatory or respiratory failures) requiring ICU admission and on mechanical ventilator support meeting inclusion and exclusion criteria The difference in the duration of mechanical ventilation in critically ill ventilated patients with liver cirrhosis when the nutritional therapy delivered as per estimated energy requirements versus measured requirements

    Measured: From date of enrollment until the date of ICU discharge /Leaving against medical advice, date of death from any cause, or off ventilatory support whichever comes first, assessed up to 28 days.

Secondary outcomes (6)
  1. Change in metabolic profile

    The effect of nutritional therapy as per estimated energy requirements versus measured requirements in critically ill ventilated patients with liver cirrhosis on the Insulin resistance, ketone bodies, Non-esterified fatty acids (NEFA), amino acids profile and blood sugar levels would be studied

    Measured: The metabolic parameters would be assessed at the baseline, Day 7 and at Day 15 of enrollment

  2. Change in inflammatory milieu

    The effect of nutritional therapy as per estimated energy requirements versus measured requirements in critically ill ventilated patients with liver cirrhosis on the levels of interleukin 6 (IL-6), Tumor necrosis factor(TNF alfa), CRP(C reactive protein)would be studied

    Measured: The inflammatory markers would be assessed at the baseline, Day 7 and at Day 15 of enrollment

  3. Change in clinical parameters

    The effect of nutritional therapy as per estimated energy requirements versus measured requirements in critically ill ventilated patients with liver cirrhosis ondevelopment of new onset infection, resolution of sepsis, renal function and length of stay in the ICU/hospital would be studied

    Measured: The clinical parameters would be assessed daily from the date of enrollment until the date of ICU discharge, date of death from any cause, or out of mechanical ventilatory support whichever comes first, assessed up to 28 days.

  4. Change in ventilatory and arterial blood gas parameters

    The effect of nutritional therapy as per estimated energy requirements versus measured requirements in critically ill ventilated patients with liver cirrhosis on ventilator parameters (FiO2, PEEP, PF ratio) and arterial blood gas parameters( PO2, PCO2, lactate, SpO2) would be studied

    Measured: The ventilatory and arterial blood gas parameters would be assessed daily from the date of enrollment until the date of ICU discharge, date of death from any cause, or out of mechanical ventilatory support whichever comes first, assessed up to 28 days.

  5. Change in nutritional parameters

    The effect of nutritional therapy as per estimated energy requirements versus measured requirements in critically ill ventilated patients with liver cirrhosis on nutritional parameters( NUTRIC score, feed intolerance and would be studied

    Measured: The nutritional parameters would be assesses at regular intervals maximum upto 28 days

  6. The association between energy metabolism, nutritional status and disease severity in patients with CLD

    The association between energy metabolism (resting energy expenditure- REE, substrate utilization and macronutrient oxidation), nutritional status (by body composition and anthropometry)and disease severity in patients with CLD (CTP and MELD scores) would be studied

    Measured: one day (Observational)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Mar 2019
  2. Study start12 Mar 2019
  3. Primary completion31 Aug 2022
  4. Study completion31 Aug 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
83 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03871894
Sponsor's protocol ID
ILBS-METALIC01
Acronym
METALIC
Status last verified
Sep 2022
First submitted
26 Feb 2019
Last updated
24 Oct 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Indirect calorimetry based nutritional intervention till patient in ICU(Intensive care unit) and Standard and fixed nutritional intervention till patient in ICU in people with Liver Cirrhoses, run by Institute of Liver and Biliary Sciences, India at 1 site in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 22 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Part 1: An Observational study (time frame: One day (Observational)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Oct 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in